Pharmacological Management of Parkinson's Disease Flashcards
Common characteristics of Parkinson’s disease
Resting tremor
Bradykinesia
Rigidity
Postural Instability
What causes Parkinson’s Disease?
Slow progressive degeneration of Dopamine-Secreting neurons in the Basal Ganglia.
Combination of genetic & environmental factors.
One of the most prevalent neurological disorders.
What is the main purpose of Parkinson’s medication?
Normalize dopamine activity in the basal ganglia
Genetic factors in Parkinson’s Disease
Mutated genes, formation of Lewy bodies in neuronal tissues, abnormal protein accumulation, & free radicals (unpaired electron)
Primary drug used to treat Parkinson’s Disease
Levodopa
Levodopa
Precursor to dopamine. Crosses BBB and is transformed into dopamine by an enzyme. Dose is slowly increased until symptoms occur; 2-3 doses per day.
Improves bradykinesia & rigidity
What happens when Levodopa & Dopa Decarboxylase meet in the periphery?
Conversion within the periphery into dopamine, but it becomes useless because dopamine cannot cross the BBB
Carbidopa
Peripheral decarboxylase inhibitor - Allows more levodopa to reach the brain before conversion into dopamine
Levodopa + Carbidopa
Sinemet
Side Effects of Levodopa
GI distress, cardiac problems, dyskinesias, behavioral changes
Effects of prolonged Levodopa
Less effective over time (3-4 years)
Due to drug tolerance and progression of disease
End of Dose Akinesia
Effectiveness of Levodopa wears off prior to next dose
On-Off Phenomenon
Effectiveness of Levodopa spontaneously decreases resulting in worse Parkinsonian symptoms. Can occur repeatedly throughout the day
Freezing
Patients stop walking and appear to be frozen due to fluctuating levodopa levels, variations in cerebral blood flow, or disruption in symmetric motor control
Drug Holiday
Gradual removal of anti-Parkinson medication for 3 days - 3 weeks after meds begin losing effectiveness. Allows body to recover from drug toxicity or tolerance due to prolonged Levodopa use
50-70% of people benefit